{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:08:47Z","timestamp":1794265727799,"version":"4.9.0"},"reference-count":59,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,3,2]]},"abstract":"<jats:title>Key Points<\/jats:title>\n                  <jats:p>A point mutation in murine factor H (W1206R) impairs its interaction with host cells but does not affect its complement-regulating activity. W1206R mutant mice develop complement-mediated systemic thrombotic angiopathy leading to renal failure, stroke, and retinopathy.<\/jats:p>","DOI":"10.1182\/blood-2016-07-728253","type":"journal-article","created":{"date-parts":[[2017,1,5]],"date-time":"2017-01-05T22:00:30Z","timestamp":1483653630000},"page":"1184-1196","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":58,"title":["Murine systemic thrombophilia and hemolytic uremic syndrome from a factor H point mutation"],"prefix":"10.1182","volume":"129","author":[{"given":"Yoshiyasu","family":"Ueda","sequence":"first","affiliation":[{"name":"Department of Systems Pharmacology and Translational Therapeutics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran","family":"Mohammed","sequence":"additional","affiliation":[{"name":"Department of Systems Pharmacology and Translational Therapeutics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delu","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damodar","family":"Gullipalli","sequence":"additional","affiliation":[{"name":"Department of Systems Pharmacology and Translational Therapeutics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Systems Pharmacology and Translational Therapeutics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Systems Pharmacology and Translational Therapeutics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Systems Pharmacology and Translational Therapeutics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuchi","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongjian","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialing","family":"Bao","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, The Children\u2019s Hospital of Philadelphia, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Mao","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, The Children\u2019s Hospital of Philadelphia, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Brass","sequence":"additional","affiliation":[{"name":"Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X. Long","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, The Children\u2019s Hospital of Philadelphia, Philadelphia, PA;"},{"name":"Division of Laboratory Medicine, Department of Pathology, University of Alabama at Birmingham, Birmingham, AL; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Miwa","sequence":"additional","affiliation":[{"name":"Department of Systems Pharmacology and Translational Therapeutics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Palmer","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Dunaief","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chao","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Systems Pharmacology and Translational Therapeutics,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"1","key":"2019111904123362100_B1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/cr.2009.139","article-title":"Complement and its role in innate and adaptive immune responses","volume":"20","author":"Dunkelberger","year":"2010","journal-title":"Cell Res"},{"issue":"14","key":"2019111904123362100_B2","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","article-title":"Complement. First of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"N Engl J Med"},{"issue":"4","key":"2019111904123362100_B3","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.molimm.2004.02.005","article-title":"The human complement factor H: functional roles, genetic variations and disease associations","volume":"41","author":"Rodr\u00edguez de C\u00f3rdoba","year":"2004","journal-title":"Mol Immunol"},{"issue":"8","key":"2019111904123362100_B4","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.it.2008.04.008","article-title":"Factor H family proteins and human diseases","volume":"29","author":"J\u00f3zsi","year":"2008","journal-title":"Trends Immunol"},{"issue":"4","key":"2019111904123362100_B5","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1073\/pnas.75.4.1971","article-title":"Regulation by membrane sialic acid of beta1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway","volume":"75","author":"Fearon","year":"1978","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"2019111904123362100_B6","doi-asserted-by":"crossref","first-page":"6308","DOI":"10.4049\/jimmunol.177.9.6308","article-title":"Critical role of the C-terminal domains of factor H in regulating complement activation at cell surfaces","volume":"177","author":"Ferreira","year":"2006","journal-title":"J Immunol"},{"issue":"10","key":"2019111904123362100_B7","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1016\/j.molimm.2006.12.001","article-title":"The C-terminus of complement factor H is essential for host cell protection","volume":"44","author":"J\u00f3zsi","year":"2007","journal-title":"Mol Immunol"},{"issue":"6","key":"2019111904123362100_B8","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1084\/jem.20070664","article-title":"Complement factor H and the hemolytic uremic syndrome","volume":"204","author":"Atkinson","year":"2007","journal-title":"J Exp Med"},{"issue":"1","key":"2019111904123362100_B9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3390\/biom2010046","article-title":"Factor h: a complement regulator in health and disease, and a mediator of cellular interactions","volume":"2","author":"Kopp","year":"2012","journal-title":"Biomolecules"},{"issue":"4","key":"2019111904123362100_B10","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/ng912","article-title":"Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H","volume":"31","author":"Pickering","year":"2002","journal-title":"Nat Genet"},{"issue":"1","key":"2019111904123362100_B11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1681\/ASN.2012060570","article-title":"Combination of factor H mutation and properdin deficiency causes severe C3 glomerulonephritis","volume":"24","author":"Lesher","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"2019111904123362100_B12","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1681\/ASN.V122297","article-title":"The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20","volume":"12","author":"Caprioli","year":"2001","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"2019111904123362100_B13","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1086\/318201","article-title":"Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome","volume":"68","author":"P\u00e9rez-Caballero","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"2","key":"2019111904123362100_B14","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1086\/318203","article-title":"Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition","volume":"68","author":"Richards","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"5720","key":"2019111904123362100_B15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1126\/science.1109557","article-title":"Complement factor H polymorphism in age-related macular degeneration","volume":"308","author":"Klein","year":"2005","journal-title":"Science"},{"issue":"5720","key":"2019111904123362100_B16","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1126\/science.1110359","article-title":"Complement factor H variant increases the risk of age-related macular degeneration","volume":"308","author":"Haines","year":"2005","journal-title":"Science"},{"issue":"5720","key":"2019111904123362100_B17","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1126\/science.1110189","article-title":"Complement factor H polymorphism and age-related macular degeneration","volume":"308","author":"Edwards","year":"2005","journal-title":"Science"},{"issue":"1","key":"2019111904123362100_B18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1086\/431426","article-title":"Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration","volume":"77","author":"Zareparsi","year":"2005","journal-title":"Am J Hum Genet"},{"issue":"9318","key":"2019111904123362100_B19","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/S0140-6736(02)08560-4","article-title":"Combined kidney and liver transplantation for familial haemolytic uraemic syndrome","volume":"359","author":"Remuzzi","year":"2002","journal-title":"Lancet"},{"issue":"11","key":"2019111904123362100_B20","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.4049\/jimmunol.0804031","article-title":"The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome","volume":"182","author":"Ferreira","year":"2009","journal-title":"J Immunol"},{"issue":"6","key":"2019111904123362100_B21","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.4049\/jimmunol.1202536","article-title":"Deletion of Crry and DAF on murine platelets stimulates thrombopoiesis and increases factor H-dependent resistance of peripheral platelets to complement attack","volume":"190","author":"Barata","year":"2013","journal-title":"J Immunol"},{"issue":"25","key":"2019111904123362100_B22","doi-asserted-by":"crossref","first-page":"14577","DOI":"10.1073\/pnas.261428398","article-title":"Complement activation in factor D-deficient mice","volume":"98","author":"Xu","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"2019111904123362100_B23","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1182\/blood-2008-05-157966","article-title":"Complement-dependent T-cell lymphopenia caused by thymocyte deletion of the membrane complement regulator Crry","volume":"113","author":"Miwa","year":"2009","journal-title":"Blood"},{"issue":"2","key":"2019111904123362100_B24","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1182\/blood-2007-05-089821","article-title":"Activator-specific requirement of properdin in the initiation and amplification of the alternative pathway complement","volume":"111","author":"Kimura","year":"2008","journal-title":"Blood"},{"issue":"6","key":"2019111904123362100_B25","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.4049\/jimmunol.172.6.3869","article-title":"Critical protection from renal ischemia reperfusion injury by CD55 and CD59","volume":"172","author":"Yamada","year":"2004","journal-title":"J Immunol"},{"issue":"21","key":"2019111904123362100_B26","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1182\/blood-2014-07-587139","article-title":"Platelet-delivered ADAMTS13 inhibits arterial thrombosis and prevents thrombotic thrombocytopenic purpura in murine models","volume":"125","author":"Pickens","year":"2015","journal-title":"Blood"},{"issue":"9","key":"2019111904123362100_B27","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1136\/jmg.40.9.676","article-title":"Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries","volume":"40","author":"Neumann","year":"2003","journal-title":"J Med Genet"},{"issue":"3","key":"2019111904123362100_B28","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/humu.20435","article-title":"The interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models","volume":"28","author":"Saunders","year":"2007","journal-title":"Hum Mutat"},{"issue":"4","key":"2019111904123362100_B29","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nsmb.2018","article-title":"Structural basis for engagement by complement factor H of C3b on a self surface","volume":"18","author":"Morgan","year":"2011","journal-title":"Nat Struct Mol Biol"},{"issue":"1-2","key":"2019111904123362100_B30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jim.2010.12.020","article-title":"Alternative complement pathway assessment in patients with atypical HUS","volume":"365","author":"Roumenina","year":"2011","journal-title":"J Immunol Methods"},{"key":"2019111904123362100_B31","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1750-1172-6-60","article-title":"Atypical hemolytic uremic syndrome","volume":"6","author":"Loirat","year":"2011","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"2019111904123362100_B32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.5582\/irdr.2014.01001","article-title":"Current treatment of atypical hemolytic uremic syndrome","volume":"3","author":"Kaplan","year":"2014","journal-title":"Intractable Rare Dis Res"},{"issue":"44","key":"2019111904123362100_B33","doi-asserted-by":"crossref","first-page":"41059","DOI":"10.1074\/jbc.C100515200","article-title":"Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura","volume":"276","author":"Zheng","year":"2001","journal-title":"J Biol Chem"},{"issue":"10","key":"2019111904123362100_B34","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1182\/blood-2002-05-1397","article-title":"Cloning, expression, and functional characterization of the von Willebrand factor-cleaving protease (ADAMTS13)","volume":"100","author":"Plaimauer","year":"2002","journal-title":"Blood"},{"issue":"12","key":"2019111904123362100_B35","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1182\/blood-2002-05-1401","article-title":"ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions","volume":"100","author":"Dong","year":"2002","journal-title":"Blood"},{"issue":"3","key":"2019111904123362100_B36","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.hoc.2013.02.006","article-title":"Thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: an update","volume":"27","author":"Tsai","year":"2013","journal-title":"Hematol Oncol Clin North Am"},{"key":"2019111904123362100_B37","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1146\/annurev-med-061813-013241","article-title":"ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura","volume":"66","author":"Zheng","year":"2015","journal-title":"Annu Rev Med"},{"issue":"3","key":"2019111904123362100_B38","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1172\/JCI9896","article-title":"Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen","volume":"106","author":"Ni","year":"2000","journal-title":"J Clin Invest"},{"issue":"4","key":"2019111904123362100_B39","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1538-7836.2011.04218.x","article-title":"Mechanisms underlying FeCl3-induced arterial thrombosis","volume":"9","author":"Eckly","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2019111904123362100_B40","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1084\/jem.20070301","article-title":"Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains","volume":"204","author":"Pickering","year":"2007","journal-title":"J Exp Med"},{"issue":"1","key":"2019111904123362100_B41","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/aji.12162","article-title":"Maternal and fetal alternative complement pathway activation in early severe preeclampsia","volume":"71","author":"Hoffman","year":"2014","journal-title":"Am J Reprod Immunol"},{"key":"2019111904123362100_B42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jri.2016.01.002","article-title":"Maternal plasma levels of complement Factor H in miscarriage and in normal pregnancy: a cohort study","volume":"114","author":"Savaris","year":"2016","journal-title":"J Reprod Immunol"},{"key":"2019111904123362100_B43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-3-319-18603-0_2","article-title":"Complement interactions with blood cells, endothelial cells and microvesicles in thrombotic and inflammatory conditions","volume":"865","author":"Karpman","year":"2015","journal-title":"Adv Exp Med Biol"},{"key":"2019111904123362100_B44","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.molimm.2016.02.011","article-title":"Complement factor H modulates the activation of human neutrophil granulocytes and the generation of neutrophil extracellular traps","volume":"72","author":"Schneider","year":"2016","journal-title":"Mol Immunol"},{"issue":"7","key":"2019111904123362100_B45","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.4049\/jimmunol.177.7.4794","article-title":"A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways","volume":"177","author":"Ritis","year":"2006","journal-title":"J Immunol"},{"issue":"4","key":"2019111904123362100_B46","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1182\/blood-2010-01-264051","article-title":"Complement anaphylatoxin C5a contributes to hemodialysis-associated thrombosis","volume":"116","author":"Kourtzelis","year":"2010","journal-title":"Blood"},{"issue":"3","key":"2019111904123362100_B47","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1182\/blood-2001-12-0166","article-title":"von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome","volume":"100","author":"Remuzzi","year":"2002","journal-title":"Blood"},{"issue":"3","key":"2019111904123362100_B48","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1067\/mpd.2003.79","article-title":"Severe deficiency of the specific von Willebrand factor-cleaving protease (ADAMTS 13) activity in a subgroup of children with atypical hemolytic uremic syndrome","volume":"142","author":"Veyradier","year":"2003","journal-title":"J Pediatr"},{"issue":"3","key":"2019111904123362100_B49","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1523-1755.2004.00841.x","article-title":"Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura\/hemolytic-uremic syndrome (TTP\/HUS)","volume":"66","author":"Licht","year":"2004","journal-title":"Kidney Int"},{"issue":"5","key":"2019111904123362100_B50","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1681\/ASN.2005010086","article-title":"Complement factor H mutation in familial thrombotic thrombocytopenic purpura with ADAMTS13 deficiency and renal involvement","volume":"16","author":"Noris","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2019111904123362100_B51","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/jth.13189","article-title":"The role of ADAMTS-13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies","volume":"14","author":"Phillips","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2019111904123362100_B52","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12185-015-1933-7","article-title":"Genetic variations in complement factors in patients with congenital thrombotic thrombocytopenic purpura with renal insufficiency","volume":"103","author":"Fan","year":"2016","journal-title":"Int J Hematol"},{"issue":"11","key":"2019111904123362100_B53","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1161\/ATVBAHA.113.302280","article-title":"Human complement factor H is a reductase for large soluble von Willebrand factor multimers--brief report","volume":"33","author":"Nolasco","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"2019111904123362100_B54","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1182\/blood-2013-04-495853","article-title":"The interaction between factor H and VWF increases factor H cofactor activity and regulates VWF prothrombotic status","volume":"123","author":"Rayes","year":"2014","journal-title":"Blood"},{"issue":"8","key":"2019111904123362100_B55","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1172\/JCI16651","article-title":"Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome","volume":"111","author":"Manuelian","year":"2003","journal-title":"J Clin Invest"},{"issue":"3","key":"2019111904123362100_B56","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1681\/ASN.2007080923","article-title":"The complement factor H R1210C mutation is associated with atypical hemolytic uremic syndrome","volume":"19","author":"Martinez-Barricarte","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"2019111904123362100_B57","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/ng.976","article-title":"A rare penetrant mutation in CFH confers high risk of age-related macular degeneration","volume":"43","author":"Raychaudhuri","year":"2011","journal-title":"Nat Genet"},{"issue":"7","key":"2019111904123362100_B58","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jamaophthalmol.2015.0814","article-title":"Phenotypic characterization of complement factor H R1210C rare genetic variant in age-related macular degeneration","volume":"133","author":"Ferrara","year":"2015","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"2019111904123362100_B59","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1681\/ASN.2015050580","article-title":"Molecular basis of factor H R1210C association with ocular and renal diseases","volume":"27","author":"Recalde","year":"2016","journal-title":"J Am Soc Nephrol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/9\/1184\/1402804\/blood728253.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/9\/1184\/1402804\/blood728253.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T17:00:06Z","timestamp":1658336406000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/129\/9\/1184\/36585\/Murine-systemic-thrombophilia-and-hemolytic-uremic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,2]]},"references-count":59,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,3,2]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2016-07-728253","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727176105.793529523","asserted-by":"object"}]},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,2]]}}}